glaucoma: Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
3209 |
4. Check minimum number of events
Min. number of events
3
|
3209 |
5. Include endpointsNone |
3209 |
6. Filter based on genotype QC (FinnGen only) |
3209 |
Control definitions (FinnGen only)
- Control exclude
- H7_GLAUCOMA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Use of antiglaucoma preparations and miotics
based on the number of shared cases.
Similar with more cases:
- Glaucoma
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 31315 | 19313 | 11757 |
| Only index persons | 26241 | 16426 | 9815 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.47 | 0.55 | 0.33 |
| Only index persons | 0.52 | 0.60 | 0.37 |
| Median age at first event (years) | |||
| Whole population | 71.87 | 73.07 | 69.86 |
| Only index persons | 70.67 | 71.97 | 68.49 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3209 | 1746 | 1463 |
| Unadjusted period prevalence (%) | 0.62 | 0.60 | 0.64 |
| Median age at first event (years) | 67.67 | 67.28 | 68.13 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2864
- Matched controls
- 28638
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
9992.3
323.0
755
*
H40.11
ICD-10 Finland
Low pressure glaucoma
482.5
323.0
380
9
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
+∞
323.0
502
*
S01ED51
ATC
timolol, combinations; ophthalmic
403.7
323.0
2457
424
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
1078.0
323.0
1541
30
S01EA03
ATC
apraclonidine; ophthalmic
65.2
323.0
433
78
S01EE04
ATC
travoprost; ophthalmic
106.9
323.0
704
87
WX140
NOMESCO Finland
Parabulbar anesthesy
19.6
323.0
763
521
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
9364.3
323.0
2574
32
XCK00
NOMESCO Finland
Perimetry
40.2
323.0
1185
494
S01EC04
ATC
brinzolamide; ophthalmic
277.7
323.0
1455
106
S01EA02
ATC
dipivefrine; ophthalmic
883.9
323.0
384
5
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
4.8
323.0
1973
9005
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
3549.3
323.0
327
*
S01EE05
ATC
tafluprost; ophthalmic
73.7
323.0
720
130
114
Kela drug reimbursment
Glaucoma
881.0
323.0
2695
510
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
+∞
323.0
456
*
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
49.4
323.0
433
103
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
5.6
323.0
2013
8552
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
+∞
323.0
343
*
H40.0
ICD-10 Finland
Glaucoma suspect
239.6
323.0
834
49
Z96.1
ICD-10 Finland
Presence of intraocular lens
7.8
323.0
1338
2904
CHD00
NOMESCO Finland
Laser trabeculoplasty
2272.1
323.0
530
*
S01ED01
ATC
timolol; ophthalmic
117.0
323.0
1337
213
XCW99
NOMESCO Finland
Other investigative procedure of eye
7.9
323.0
944
1673
S01EE01
ATC
latanoprost; ophthalmic
175.6
323.0
1941
338
S01EC01
ATC
acetazolamide; systemic
138.0
323.0
1117
132
S01EC03
ATC
dorzolamide; ophthalmic
259.9
323.0
805
43
XCK10
NOMESCO Finland
Photography of fundus of eye
7.7
323.0
884
1571
H40.9
ICD-10 Finland
Glaucoma, unspecified
270.1
323.0
455
20
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
1517.6
323.0
995
10
S01EC54
ATC
brinzolamide, combinations; ophthalmic
409.9
323.0
474
14
S01ED02
ATC
betaxolol; ophthalmic
130.3
323.0
460
42
S01EX03
ATC
NA
215.3
323.0
1127
86
S01EE03
ATC
bimatoprost; ophthalmic
196.1
323.0
845
61
S01EB01
ATC
pilocarpine; ophthalmic
174.5
323.0
379
25
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
4.7
319.1
1983
9288
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
8.1
297.2
742
1179
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.7
273.4
938
2263
CHC05
NOMESCO Finland
Iridotomy
94.0
267.4
295
35
XCH00
NOMESCO Finland
Eye pressure measurement
14.7
265.7
467
375
XCH05
NOMESCO Finland
Eye pressure longterm registration
544.7
255.0
250
5
CHD35
NOMESCO Finland
Laser goniopuncture
2505.5
252.7
241
*
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
+∞
227.1
215
*
CHD99
NOMESCO Finland
Other filtering operation
+∞
220.7
209
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
12.8
214.0
399
358
H40
ICD-10 Finland
Glaucoma
76.1
209.8
238
34
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
161.7
200.5
210
14
3651A
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]
+∞
196.1
186
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
41.5
188.1
237
62
CS494
NOMESCO Finland
Other visual field testing
27.5
187.1
261
104
H25.1
ICD-10 Finland
Senile nuclear cataract
3.2
184.0
1542
7659
H40.22
ICD-10 Finland
Chronic glaucoma with closed ventricular angle
+∞
162.0
154
*
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
149.5
160.2
169
12
ZXC20
NOMESCO Finland
Use of chemical agents
11.5
146.9
286
274
WX100
NOMESCO Finland
Conjunctival surface anesthesia
3.8
146.6
744
2431
CFW99
NOMESCO Finland
Other operation on conjunctiva
1501.3
146.1
141
*
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
33.1
142.6
189
61
CJB10
NOMESCO Finland
Laser discission of secondary cataract
4.1
141.4
645
1912
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
5.7
127.4
395
775
H26.4
ICD-10 Finland
After-cataract
3.6
123.6
667
2251
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
22.7
123.0
181
85
Z3229
NOMESCO Finland
Other healthcare associate professional
4.2
122.3
529
1475
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
14.4
115.1
200
148
S01BC03
ATC
diclofenac; ophthalmic
9.0
112.0
248
298
H40.8
ICD-10 Finland
Other glaucoma
553.3
108.5
107
*
ZXA05
NOMESCO Finland
Left side
2.6
108.4
1096
5533
H34.8
ICD-10 Finland
Other retinal vascular occlusions
9.0
103.8
230
276
3651B
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]
+∞
103.8
99
*
ZXA00
NOMESCO Finland
Right side
2.5
103.6
1125
5869
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
8.9
102.6
228
275
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
991.5
98.7
96
*
37510
ICD-8 Finland
Glaucoma, Chronicum simplex
+∞
97.4
93
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
4.5
92.2
356
875
ZXA10
NOMESCO Finland
Bilateral
2.6
90.4
808
3721
H26.2
ICD-10 Finland
Complicated cataract
16.5
88.6
145
92
CKC12
NOMESCO Finland
Photocoagulation of retina
6.1
85.4
245
429
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
6.0
82.7
241
430
H40.19
ICD-10 Finland
Other primary glaucoma with open ventricular angle
+∞
82.7
79
*
Z3231
NOMESCO Finland
Registered nurse
2.3
81.9
997
5356
H40.20
ICD-10 Finland
Acute glaucoma with closed ventricular angle
+∞
81.6
78
*
WX002
NOMESCO Finland
Sedation and analgesia
2.5
80.2
772
3666
H33.0
ICD-10 Finland
Retinal detachment with retinal break
7.1
79.2
204
308
H43.1
ICD-10 Finland
Vitreous haemorrhage
8.0
79.0
186
245
CKD40
NOMESCO Finland
Endophotocoagulation of retina
13.3
78.8
141
111
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
25.0
78.2
111
46
H40.1
ICD-10 Finland
Primary open-angle glaucoma
166.6
77.5
81
5
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
6.8
76.3
201
313
H16.0
ICD-10 Finland
Corneal ulcer
5.7
71.0
217
409
F93
ICPC
Glaucoma
69.3
70.7
81
12
H40.3
ICD-10 Finland
Glaucoma secondary to eye trauma
+∞
70.1
67
*
S01BC05
ATC
ketorolac; ophthalmic
3.9
69.1
309
861
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
9.7
68.6
144
156
3708
FHL
Trabeculectomy or equivalent
684.0
68.3
67
*
3650A
ICD-9 Finland
Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]
+∞
68.0
65
*
H3603, E103
ICD-10 Finland
NA
22.8
65.2
95
43
CS2P4
NOMESCO Finland
Optic nerve head imaging
104.0
65.1
71
7
H40.12
ICD-10 Finland
Pigmentary glaucoma
+∞
64.8
62
*
CHD10
NOMESCO Finland
Trabeculectomy
+∞
64.8
62
*
CKD20
NOMESCO Finland
Removal of vitreous body substitute
21.6
63.4
94
45
H21.0
ICD-10 Finland
Hyphaema
40.6
62.9
79
20
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
22.1
61.2
90
42
WX142
NOMESCO Finland
Sub-tenon anesthesy
22.1
59.9
88
41
S01FA01
ATC
atropine; ophthalmic
24.4
58.2
83
35
H04.10
ICD-10 Finland
Dry eye syndrome
3.1
57.6
350
1231
CHC03
NOMESCO Finland
Laser iridoplasty
558.5
55.8
55
*
S01FA04
ATC
cyclopentolate; ophthalmic
11.2
55.4
107
99
37597
ICD-8 Finland
Glaucoma, Suspicio glaucomatis
+∞
54.3
52
*
TCG10
NOMESCO Finland
Removal of sutures from cornea
19.6
53.7
82
43
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
56.6
51.7
61
11
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
17.2
51.3
82
49
CFB00
NOMESCO Finland
Suture of conjunctiva
112.1
50.9
55
5
ZXE00
NOMESCO Finland
One hour or less
1.9
49.8
1163
7725
H3603, E113
ICD-10 Finland
NA
11.5
49.6
94
84
H44.5
ICD-10 Finland
Degenerated conditions of globe
173.0
49.0
51
*
CKC15
NOMESCO Finland
Panretinal photocoagulation
11.0
49.0
95
89
CKD15
NOMESCO Finland
Injection of vitreous substitute
19.4
48.5
74
39
CKC20
NOMESCO Finland
Cryopexy of undetached retina
33.3
47.4
62
19
H21.1
ICD-10 Finland
Other vascular disorders of iris and ciliary body
62.2
47.4
55
9
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
7.8
47.0
111
147
SPAT1009
SPAT
Measurement of intraocular pressure
8.8
46.7
102
119
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
9.6
46.1
96
103
S01EX
ATC
Other antiglaucoma preparations
+∞
44.9
43
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
6.5
44.9
121
194
CHF15
NOMESCO Finland
Cryotherapy of ciliary body
+∞
42.8
41
*
TCG20
NOMESCO Finland
Laser suture lysis in cornea or sclera
+∞
42.8
41
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
42.1
1092
7390
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
6.9
41.3
106
159
H18.1
ICD-10 Finland
Bullous keratopathy
24.6
41.1
58
24
Z94.7
ICD-10 Finland
Corneal transplant status
19.2
40.6
62
33
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
16.0
40.5
66
42
ZXD20
NOMESCO Finland
Day surgery
2.3
40.0
421
2009
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
3.8
39.9
177
485
S01GX01
ATC
cromoglicic acid; ophthalmic
2.1
39.0
477
2436
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
4.1
38.9
158
401
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
6.8
38.2
99
151
CJ2M4
NOMESCO Finland
Scans and measurement printouts for intraocular lens power calculation
7.6
37.1
89
121
A10AA01
ATC
NA
5.2
37.0
119
238
H25.0
ICD-10 Finland
Senile incipient cataract
2.7
36.8
272
1073
CHB99
NOMESCO Finland
Other operation on anterior chamber and anterior chamber angle
131.7
36.8
39
*
CKC10
NOMESCO Finland
Local photocoagulation of retina
4.7
36.3
128
283
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
5.7
36.0
106
191
S01AX11
ATC
[U] ofloxacin; ophthalmic
3.2
34.2
194
644
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
16.5
34.2
55
34
H25.8
ICD-10 Finland
Other senile cataract
2.0
33.7
514
2858
A10AA02
ATC
NA
3.4
33.3
169
517
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
23.9
33.1
47
20
CFD10
NOMESCO Finland
Repair of conjunctiva
55.0
32.3
38
7
T85.2
ICD-10 Finland
Mechanical complication of intraocular lens
14.6
31.5
53
37
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
5.2
31.2
99
195
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
42.7
30.9
38
9
H26.02
ICD-10 Finland
Presenil cataract
4.7
30.8
107
233
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
12.7
30.8
55
44
S01EX05
ATC
netarsudil; ophthalmic
+∞
30.3
29
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
12.9
29.3
52
41
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.7
29.0
131
365
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
6.6
28.5
74
114
T89
ICPC
Diabetes insulin dependent
4.0
28.1
117
304
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
10.8
28.0
54
51
H16.9
ICD-10 Finland
Keratitis, unspecified
6.3
27.9
75
121
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
5.8
27.6
80
142
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.8
27.4
121
331
Z2221
NOMESCO Finland
Medical doctor
1.7
26.9
763
5140
H27.0
ICD-10 Finland
Aphakia
13.7
26.8
46
34
CG2T4
NOMESCO Finland
Topography assessment of cornea
9.8
26.2
53
55
37520
ICD-8 Finland
Glaucoma, Secondary
+∞
26.1
25
*
H31.4
ICD-10 Finland
Choroidal detachment
94.3
25.7
28
*
S01AD03
ATC
aciclovir; ophthalmic
3.2
25.6
141
459
CGG45
NOMESCO Finland
Full thickness transplantation of cornea using homograft
22.0
25.6
37
17
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
11.3
25.6
48
43
H27.1
ICD-10 Finland
Dislocation of lens
10.4
25.5
50
49
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
25.3
1075
8005
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
4.0
24.9
103
267
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
13.2
24.7
43
33
CWD00
NOMESCO Finland
Reoperation for superficial heamorrhage in eye and adjacent structures
131.1
24.6
26
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
24.4
292
1461
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
5.0
24.4
80
165
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
11.1
23.8
45
41
A10AE04
ATC
insulin glargine; parenteral
2.0
23.7
308
1593
H04AA01
ATC
glucagon; nasal, parenteral
5.7
23.7
69
124
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.2
23.2
250
1195
E10
ICD-10 Finland
Type 1 diabetes mellitus
6.4
22.8
60
95
XCD20
NOMESCO Finland
Photoangiography of eye
3.8
22.7
99
269
CHW99
NOMESCO Finland
Other operation on anterior chamber, anterior chamber angle, iris or ciliary body
121.0
22.6
24
*
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
3.0
22.5
131
444
CKD60
NOMESCO Finland
Anterior vitrectomy
5.5
21.7
65
121
H54.4
ICD-10 Finland
Blindness, monocular
18.5
21.7
33
18
H3601, E103
ICD-10 Finland
NA
8.6
21.3
46
54
H57.1
ICD-10 Finland
Ocular pain
3.8
20.6
89
241
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
3.1
20.5
117
391
H40.6
ICD-10 Finland
Glaucoma secondary to drugs
+∞
19.8
19
*
H36.01
ICD-10 Finland
Diabetic maculopathy
5.0
19.8
64
131
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
19.6
331
1882
F43
ICPC
Eye, Other diagnostic procedure
4.6
19.6
68
150
H54.1
ICD-10 Finland
Severe visual impairment, binocular
17.8
19.5
30
17
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
19.4
659
4592
H01.0
ICD-10 Finland
Blepharitis
2.6
19.1
141
554
XCW10
NOMESCO Finland
Assessment of vision
10.1
18.8
37
37
37512
ICD-8 Finland
Glaucoma, Chronicum capsulare
+∞
18.8
18
*
S01EB02
ATC
carbachol; ophthalmic
+∞
18.8
18
*
3652B
ICD-9 Finland
Glaucoma, Primary angle-closure glaucoma[KROONINEN AHDASKULMAGLAUKOOMA]
+∞
18.8
18
*
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
7.4
18.7
44
60
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
9.4
18.6
38
41
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.6
18.5
135
529
F99
ICPC
Eye/adnexa disease other
8.4
18.4
40
48
H33.4
ICD-10 Finland
Traction detachment of retina
13.6
18.2
31
23
H3600, E103
ICD-10 Finland
NA
7.5
17.6
41
55
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
17.6
1203
9661
3711
FHL
Cyclodiateria or cryocoagulation
181.0
17.5
18
*
R3120
NOMESCO Finland
Training in mobility skills
31.6
17.0
22
7
CJF30
NOMESCO Finland
Reduction of dislocation of artificial lens
10.8
16.9
32
30
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.4
16.9
143
607
H52.1
ICD-10 Finland
Myopia
4.2
16.9
64
155
H40.29
ICD-10 Finland
Other [primary] glaucoma with closed ventricular angle
+∞
16.7
16
*
3656X
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]
+∞
16.7
16
*
3641A
ICD-9 Finland
Disorders of iris and ciliary body, Chronic iridocyclitis
35.2
16.7
21
6
CGG60
NOMESCO Finland
Reinforcement of sclera using graft
90.6
16.6
18
*
C08CA01
ATC
amlodipine; oral
1.4
16.1
1107
8856
J01DB01
ATC
cefalexin; oral
1.4
16.1
2028
18057
S01FA02
ATC
scopolamine; ophthalmic
5.5
16.0
47
87
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
21.1
16.0
23
11
WX110
NOMESCO Finland
Local anesthesy
1.4
16.0
1489
12564
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
15.9
808
6102
CWW99
NOMESCO Finland
Other reoperation on eye and adjacent structures
60.3
15.8
18
*
H18.2
ICD-10 Finland
Other corneal oedema
15.7
15.7
25
16
H20.8
ICD-10 Finland
Other iridocyclitis
15.7
15.7
25
16
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
7.0
15.6
38
55
H30.2
ICD-10 Finland
Posterior cyclitis
17.3
15.6
24
14
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
22.2
15.5
22
10
S01BA09
ATC
clobetasone; ophthalmic
38.3
15.4
19
5
H02.4
ICD-10 Finland
Ptosis of eyelid
2.8
15.3
98
354
H35.36
ICD-10 Finland
Macular cyst
6.1
15.3
41
68
3626
FHL
Extracapsular cataract surgery and implantation of an artificial lens
2.9
15.2
94
334
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.7
15.2
104
394
CKD50
NOMESCO Finland
Endodiathermy of retina
20.1
15.1
22
11
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
14.9
521
3623
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
15.1
14.9
24
16
3663A
ICD-9 Finland
Cataract secondary to ocular disorders
12.5
14.8
26
21
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
6.3
14.8
39
63
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.7
14.8
300
1804
TCA15
NOMESCO Finland
Retrobulbar therapeutic injection into orbit
57.0
14.8
17
*
H3603, E109
ICD-10 Finland
NA
57.0
14.8
17
*
A10AE05
ATC
insulin detemir; parenteral
2.1
14.8
161
774
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.9
14.7
223
1219
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
9.8
14.7
29
30
H26.3
ICD-10 Finland
Drug-induced cataract
7.5
14.7
34
46
3703
FHL
Laser operation on ventricular angle under general anesthesia
+∞
14.6
14
*
L04AB04
ATC
adalimumab; parenteral
4.9
14.5
47
98
Q15.0
ICD-10 Finland
Congenital glaucoma
150.7
14.5
15
*
3719
FHL
Other measure in this category
150.7
14.5
15
*
SPAT1262
SPAT
Handing over of treatment supplies
1.5
14.4
510
3557
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
14.3
1778
15596
CG2S4
NOMESCO Finland
Photography of cornea
9.1
14.2
29
32
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.3
14.1
51
119
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
5.3
14.0
42
80
F38
ICPC
Eye, Other laboratory test NEC
10.9
14.0
26
24
CJF15
NOMESCO Finland
Secondary implantation of skleral fixed artificial lens in posterior chamber
14.8
13.6
22
15
ZXD05
NOMESCO Finland
Urgent procedure
1.4
13.5
793
6118
CKC60
NOMESCO Finland
Local buckling of sclera using implant
6.8
13.4
33
49
CA1ME
NOMESCO Finland
Ultrasound oculometry
5.1
13.3
41
81
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
8.1
13.3
29
36
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
13.8
13.2
22
16
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.6
13.2
59
167
H3603, E107
ICD-10 Finland
NA
40.2
13.1
16
*
J01CA04
ATC
amoxicillin; systemic
1.4
13.0
1908
17047
H54.0
ICD-10 Finland
Blindness, binocular
16.8
13.0
20
12
CDC00
NOMESCO Finland
Enucleation of eye
28.5
12.9
17
6
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
8.1
12.8
28
35
CKC70
NOMESCO Finland
Circular buckling of sclera
8.5
12.7
27
32
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
12.7
450
3135
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
1.9
12.6
179
956
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
5.9
12.5
34
58
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.6
12.5
90
352
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
4.9
12.5
40
83
CHC00
NOMESCO Finland
Iridotomy
130.5
12.4
13
*
A98
ICPC
Health maint/preventive medicine
1.4
12.4
2331
21600
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
3.2
12.3
63
199
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
14.4
12.3
20
14
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
7.0
12.1
29
42
H44.4
ICD-10 Finland
Hypotony of eye
46.8
11.9
14
*
CK2P4
NOMESCO Finland
Optic nerve head light layer imaging (OCT)
46.8
11.9
14
*
S01KA02
ATC
hypromellose; ophthalmic
2.9
11.8
70
244
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
11.8
535
3917
A11CC03
ATC
alfacalcidol; systemic
2.7
11.6
78
295
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
5.0
11.5
36
73
H02AB06
ATC
prednisolone; systemic
1.3
11.5
1188
9986
CKD95
NOMESCO Finland
Extended combined vitectomy and lens procedure through pars plana
8.6
11.5
24
28
CJF45
NOMESCO Finland
Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy
10.1
11.5
22
22
3656F
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA POST UVEITIDEM]
+∞
11.5
11
*
3661A
ICD-9 Finland
Cataract, Senile cataract
2.7
11.5
76
284
JLE03
NOMESCO Finland
Allogenic total transplantation of pancreas with pancreaticoenterostomy
120.5
11.4
12
*
127
Kela drug reimbursment
Transplant complication
4.3
11.3
41
97
TK800
NOMESCO Finland
Hemodialysis
3.1
11.3
62
206
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.7
10.9
72
267
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
6.3
10.9
28
45
H54.5
ICD-10 Finland
Severe visual impairment, monocular
7.8
10.9
24
31
N02BE01
ATC
paracetamol; systemic, rectal
1.4
10.8
2258
20940
CHB15
NOMESCO Finland
Puncture of anterior chamber of eye with replacement of aqueous
21.5
10.7
15
7
H3601, E113
ICD-10 Finland
NA
2.9
10.6
64
227
A02BC02
ATC
pantoprazole; systemic
1.3
10.6
1652
14646
J01AA02
ATC
doxycycline; systemic
1.3
10.5
1951
17712
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.2
10.5
106
495
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
7.3
10.4
24
33
H01.1
ICD-10 Finland
Noninfectious dermatoses of eyelid
7.3
10.4
24
33
H53.4
ICD-10 Finland
Visual field defects
2.8
10.4
66
241
N0830, E102
ICD-10 Finland
NA
110.4
10.4
11
*
CHB30
NOMESCO Finland
Goniotomy
+∞
10.4
10
*
165
Kela drug reimbursment
Preservative-free combination of bimatoprost and timolol
+∞
10.4
10
*
CGG99
NOMESCO Finland
Other reconstructive operations on cornea and sclera
32.6
10.3
13
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
10.3
982
8121
H18.8
ICD-10 Finland
Other specified disorders of cornea
5.3
10.3
30
57
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
7.1
10.3
24
34
H10.5
ICD-10 Finland
Blepharoconjunctivitis
3.6
10.2
44
123
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.7
10.2
215
1310
L04AA17
ATC
[U] adalimumab; parenteral
14.6
10.0
16
11
CJF20
NOMESCO Finland
Removal of artificial lens
14.6
10.0
16
11
H35.29
ICD-10 Finland
Other proliferative retinopathy
40.2
10.0
12
*
L04AA06
ATC
mycophenolic acid; systemic
3.6
9.9
43
121
J01FF01
ATC
clindamycin; systemic
1.4
9.8
597
4596
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
5.2
9.8
29
56
H31.3
ICD-10 Finland
Choroidal haemorrhage and rupture
26.1
9.8
13
5
A10AE06
ATC
insulin degludec; parenteral
2.9
9.8
58
204
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
5.4
9.8
28
52
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.0
9.8
38
97
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
4.8
9.7
31
65
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.0
9.6
53
178
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
9.6
603
4661
F29
ICPC
Eye symptom/complaint other
1.7
9.6
181
1067
Z94.0
ICD-10 Finland
Kidney transplant status
4.3
9.6
34
80
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
11.4
9.5
17
15
CJF10
NOMESCO Finland
Secondary implantation of artificial lens in posterior chamber
11.4
9.5
17
15
196
Kela drug reimbursment
Paricalcitol and cinacalcet
8.4
9.5
20
24
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
9.5
517
3901
CGG31
NOMESCO Finland
Posterior corneal lamellar transplantation
10.1
9.5
18
18
H221, M084
ICD-10 Finland
NA
+∞
9.4
9
*
3659X
ICD-9 Finland
Glaucoma, Unspecified glaucoma
+∞
9.4
9
*
CHB50
NOMESCO Finland
Trabeculotomy
+∞
9.4
9
*
CHC10
NOMESCO Finland
Peripheral iridectomy
+∞
9.4
9
*
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.2
9.3
48
154
V03AE02
ATC
sevelamer; oral
6.9
9.3
22
32
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.9
9.3
22
32
H36.00
ICD-10 Finland
Diabetic background retinopathy
3.2
9.2
47
150
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.7
9.2
179
1065
CKD99
NOMESCO Finland
Other intraoclular operations on vitreous body and retina
13.7
9.2
15
11
C10AA01
ATC
simvastatin; oral
1.3
9.1
1338
11668
H3600, E113
ICD-10 Finland
NA
2.9
9.1
53
185
H33.3
ICD-10 Finland
Retinal breaks without detachment
2.2
9.1
86
391
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.8
9.0
151
855
L04AA01
ATC
[U] ciclosporin; systemic
3.2
9.0
44
137
36402
ICD-8 Finland
Iritis, Iridocyclitis, uveitis chronica
18.6
8.9
13
7
H18.4
ICD-10 Finland
Corneal degeneration
7.5
8.9
20
27
E0000UV
ATC
NA
1.3
8.9
900
7471
H18.6
ICD-10 Finland
Keratoconus
6.8
8.8
21
31
CJE15
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in anterior chamber and iridectomy or iridotomy
3.1
8.8
46
150
CJF00
NOMESCO Finland
Secondary implantation of artificial lens in anterior chamber
10.7
8.8
16
15
R03AC02
ATC
salbutamol; inhalant
1.3
8.7
1159
9957
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.4
8.7
70
294
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
8.7
856
7071
S01FA06
ATC
tropicamide; ophthalmic
11.6
8.6
15
13
S05.6
ICD-10 Finland
Penetrating wound of eyeball without foreign body
11.6
8.6
15
13
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
4.2
8.6
31
75
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
9.0
8.5
17
19
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
8.5
681
5464
H34.1
ICD-10 Finland
Central retinal artery occlusion
4.1
8.4
31
76
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
5.6
8.4
23
41
37598
ICD-8 Finland
Glaucoma, Aliud definitum
+∞
8.3
8
*
S01EXXX
ATC
NA
+∞
8.3
8
*
3702
FHL
Trabeculotomy
+∞
8.3
8
*
3652A
ICD-9 Finland
Glaucoma, Primary angle-closure glaucoma[AKUUTTI AHDASKULMAGLAUKOOMA]
+∞
8.3
8
*
37511
ICD-8 Finland
Glaucoma, Chronicum irritativum sive congestivum
+∞
8.3
8
*
3651D
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA PIGMENTOSUM]
+∞
8.3
8
*
3650B
ICD-9 Finland
Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AHDASKULMA)]
+∞
8.3
8
*
WX144
NOMESCO Finland
Subconjunctival anesthesy
2.8
8.3
50
180
M45
ICD-10 Finland
Ankylosing spondylitis
3.0
8.2
45
153
CK9F4
NOMESCO Finland
Fluorescein angiography (FAG) of choroid and retina
4.5
8.2
27
60
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.6
8.0
186
1167
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
8.0
390
2880
Z5132
NOMESCO Finland
Nursing associate professional
4.7
7.9
25
53
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.7
7.9
152
905
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
2.6
7.9
56
222
A28
ICPC
Limited function/disability NOS
1.3
7.9
532
4153
H22.0*B02.3
ICD-10 Finland
Zoster iridocyclitis
10.8
7.8
14
13
H17.9
ICD-10 Finland
Corneal scar and opacity, unspecified
10.8
7.8
14
13
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.5
7.8
34
98
H04.3
ICD-10 Finland
Acute and unspecified inflammation of lacrimal passages
4.8
7.7
24
50
H02AB04
ATC
methylprednisolone; systemic
1.4
7.7
343
2490
CDC40
NOMESCO Finland
Evisceration of eye with insertion of prosthesis
45.1
7.7
9
*
CHD60
NOMESCO Finland
Deep sclerectomy without implant
45.1
7.7
9
*
3610A
ICD-9 Finland
Retinal detachments and defects, Retinal detachment with retinal defect
5.9
7.7
20
34
H46
ICD-10 Finland
Optic neuritis
7.4
7.7
17
23
4AA12
NOMESCO Finland
NA
18.4
7.6
11
6
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
11.9
7.6
13
11
CJG15
NOMESCO Finland
Extraction of dislocated lens with implantation of artificial lens in anterior chamber and iridectomy or iridotomy
25.1
7.6
10
*
AA1AD
NOMESCO Finland
CT of head and brain
1.3
7.5
665
5394
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
8.9
7.5
15
17
Z49.0
ICD-10 Finland
Preparatory care for dialysis
3.8
7.5
30
80
CD2S4
NOMESCO Finland
Photography of eye
5.7
7.5
20
35
CBG00
NOMESCO Finland
Epilation of cilia by electrolysis
5.7
7.5
20
35
A10AA03
ATC
NA
3.1
7.5
39
128
T90
ICPC
Diabetes non-insulin dependent
1.3
7.4
571
4540
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
80.3
7.4
8
*
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
7.7
7.4
16
21
J05AB01
ATC
aciclovir; systemic
1.4
7.4
450
3455
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
7.3
179
1137
S01EB03
ATC
ecothiopate; ophthalmic
+∞
7.3
7
*
H221, M083
ICD-10 Finland
NA
+∞
7.3
7
*
CHD30
NOMESCO Finland
Laser trabeculectomy
+∞
7.3
7
*
H3603, H405
ICD-10 Finland
NA
+∞
7.3
7
*
CHD20
NOMESCO Finland
Posterior sclerotomy
+∞
7.3
7
*
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.8
7.3
110
606
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
1.8
7.3
130
755
H15.1
ICD-10 Finland
Episcleritis
4.0
7.3
27
68
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
20.1
7.1
10
5
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
7.9
7.1
15
19
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
7.1
342
2519
S01BC01
ATC
indometacin; ophthalmic
12.0
7.1
12
10
F27
ICPC
Fear of eye disease
3.8
7.0
28
75
H33.5
ICD-10 Finland
Other retinal detachments
4.3
7.0
24
56
L04AD01
ATC
ciclosporin; systemic
3.1
7.0
35
113
S05.1
ICD-10 Finland
Contusion of eyeball and orbital tissues
3.2
6.9
34
108
H05BX01
ATC
cinacalcet; oral
4.6
6.9
22
48
R53
ICD-10 Finland
Malaise and fatigue
1.3
6.9
560
4487
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
6.7
6.8
16
24
S01XA18
ATC
ciclosporin; ophthalmic
5.0
6.8
20
40
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
6.8
532
4242
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
40.1
6.8
8
*
3793C
ICD-9 Finland
Other disorders of eye, Aphakia and other disorders of lens[PSEUDOPHAKIA]
3.7
6.8
27
73
ZYC01
NOMESCO Finland
Remote contact by phone
1.9
6.7
86
448
0147
NOMESCO Finland
NA
16.7
6.7
10
6
WX720
NOMESCO Finland
Own respiration
2.0
6.7
79
398
B05DA
ATC
Isotonic solutions
4.7
6.7
21
45
C08CA13
ATC
lercanidipine; oral
1.4
6.7
370
2795
H10.4
ICD-10 Finland
Chronic conjunctivitis
3.9
6.7
25
64
CKW99
NOMESCO Finland
Other operation on choroid, vitreous body and retina
3.4
6.6
29
85
H25.2
ICD-10 Finland
Senile cataract, morgagnian type
3.4
6.6
29
85
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
3.7
6.6
26
70
V03AE03
ATC
lanthanum carbonate; oral
6.8
6.5
15
22
S05.0
ICD-10 Finland
Injury of conjunctiva and corneal abrasion without mention of foreign body
2.8
6.5
38
135
H02AB07
ATC
prednisone; oral
1.4
6.5
354
2666
CBJ30
NOMESCO Finland
Plastic repair of levator aponeurosis of eyelid
4.5
6.5
21
47
R01AD08
ATC
fluticasone; nasal
1.3
6.4
518
4137
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
6.4
741
6204
Z2446
NOMESCO Finland
Social worker
1.6
6.4
146
913
CWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in eye and adjacent structures
70.0
6.4
7
*
S01XA02
ATC
retinol; ophthalmic
3.5
6.4
27
77
J01MA02
ATC
ciprofloxacin; systemic
1.2
6.4
987
8550
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.9
6.4
81
423
H33.2
ICD-10 Finland
Serous retinal detachment
6.5
6.3
15
23
S01AA12
ATC
tobramycin; ophthalmic
5.2
6.3
18
35
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
5.2
6.3
18
35
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
6.3
123
736
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
6.3
996
8641
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
11.0
6.3
11
10
71200
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis
11.0
6.3
11
10
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
4.0
6.3
23
58
C03CA01
ATC
furosemide; systemic
1.2
6.3
1048
9149
S01FB01
ATC
phenylephrine; ophthalmic (sympathomimetics excl. antiglaucoma prep.)
18.0
6.3
9
5
ZZL00
NOMESCO Finland
Free graft of amniotic membrane
18.0
6.3
9
5
3656C
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA NEOVASCULARE]
+∞
6.2
6
*
CGG20
NOMESCO Finland
Epikeratofakia or keratofakia
+∞
6.2
6
*
H40.2
ICD-10 Finland
Primary angle-closure glaucoma
+∞
6.2
6
*
3651E
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA INFANTILE SEU JUVENILE]
+∞
6.2
6
*
S01EA01
ATC
epinephrine; ophthalmic
+∞
6.2
6
*
3651C
ICD-9 Finland
Glaucoma, Open-angle glaucoma[MATALAPAINEGLAUKOOMA]
+∞
6.2
6
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.8
6.2
107
618
H3603, E117
ICD-10 Finland
NA
26.7
6.2
8
*
H360, E113
ICD-10 Finland
NA
26.7
6.2
8
*
H18.3
ICD-10 Finland
Changes in corneal membranes
26.7
6.2
8
*
A02BC05
ATC
esomeprazole; systemic
1.2
6.2
917
7899
SPAT1325
SPAT
Vaccination
1.2
6.2
939
8109
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.7
6.2
120
719
I95.9
ICD-10 Finland
Hypotension, unspecified
2.5
6.1
45
184
S01GX08
ATC
ketotifen; ophthalmic
2.1
6.1
61
287
N18.0
ICD-10 Finland
End-stage renal disease
2.7
6.1
40
152
SPAT1014
SPAT
Treatment of eyes
2.2
6.1
58
266
CM2X4
NOMESCO Finland
Follow-up OCT of age-related macular degeneration lesions
3.2
6.1
29
91
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
4.0
6.1
22
55
3620B
ICD-9 Finland
Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]
12.5
6.1
10
8
3792A
ICD-9 Finland
Other disorders of eye, Disorders of vitreous body
12.5
6.1
10
8
H3602, E103
ICD-10 Finland
NA
12.5
6.1
10
8
XQ800
NOMESCO Finland
Prick test
1.8
6.1
105
607
CGF10
NOMESCO Finland
Suture of laceration of cornea
8.6
6.0
12
14
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
6.0
388
3000
CJD20
NOMESCO Finland
Extracapsular cataract extraction with implantation of artificial lens in posterior chamber
6.7
6.0
14
21
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
6.7
6.0
14
21
N20.1
ICD-10 Finland
Calculus of ureter
1.9
6.0
82
437
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.4
6.0
266
1928
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002385) Erythrocyte distribution width [Ratio]
2178
18361
1.58
30.63
25.6
21.6
%
14.0
14.0
0.45
2128
17881
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
23
15
15.44
26.24
7.9
7.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1121
8393
1.52
25.83
6.7
5.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
489
3004
1.74
25.53
2.2
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2713
24611
1.66
23.33
25.0
21.1
mmol/l
139.3
139.5
2.94
2633
23864
(3023103) Potassium [Moles/volume] in Serum or Plasma
2716
24655
1.66
23.17
25.4
21.3
mmol/l
4.0
4.0
0.02
2632
23862
(3042733) HLA Ab [Presence] in Serum
27
31
8.78
21.54
5.7
4.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2608
23554
1.57
21.46
21.3
17.7
mg/l
25.8
26.9
0.90
2191
19373
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2212
19353
1.46
20.82
8.0
7.4
u/l
81.3
81.7
0.11
2071
17967
(3022096) Basophils/100 leukocytes in Blood
1363
10930
1.43
20.76
7.2
5.6
%
0.6
0.6
0.18
1261
10038
(3037467) Urinalysis macro (dipstick) panel - Urine
2027
17499
1.43
20.11
5.5
4.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1396
11301
1.42
19.88
7.2
5.6
%
59.7
58.8
2.01
1289
10399
(3019198) Lymphocytes [#/volume] in Blood
1483
12136
1.41
19.84
7.2
5.5
e9/l
1.9
1.9
0.02
1294
10425
(3002030) Lymphocytes/100 leukocytes in Blood
1416
11498
1.41
19.78
7.5
5.8
%
25.3
26.0
1.31
1305
10524
(3006504) Eosinophils/100 leukocytes in Blood
1388
11232
1.42
19.77
7.2
5.7
%
2.9
2.8
1.37
1285
10310
(3026250) Tacrolimus [Mass/volume] in Blood
33
53
6.28
19.73
44.3
27.8
ug/l
7.5
6.6
1.28
33
45
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1458
11908
1.41
19.66
2.2
2.1
pmol/l
95.1
93.4
0.58
683
6030
(3019069) Monocytes/100 leukocytes in Blood
1391
11282
1.41
19.45
7.5
6.0
%
9.0
8.9
0.39
1290
10379
(3018418) pH of Serum or Plasma
1068
8282
1.43
19.15
5.5
3.8
ph
7.4
7.4
2.95
222
1489
(3006315) Basophils [#/volume] in Blood
1453
11898
1.40
19.11
6.9
5.4
e9/l
0.0
0.0
1.12
1252
10050
(3007461) Platelets [#/volume] in Blood
2751
25326
1.60
19.00
30.8
25.9
e9/l
245.4
242.9
1.09
2652
24462
(3024731) MCV [Entitic volume]
2751
25331
1.60
18.93
30.7
25.8
fl
92.1
91.6
5.23
2690
24744
(3035941) MCH [Entitic mass]
2751
25332
1.60
18.91
30.6
25.8
pg
30.4
30.3
1.28
2691
24744
(3026361) Erythrocytes [#/volume] in Blood
2751
25333
1.60
18.90
30.8
25.9
e12/l
4.3
4.4
7.14
2630
24367
(3000963) Hemoglobin [Mass/volume] in Blood
2751
25339
1.60
18.81
31.1
26.1
g/l
129.7
131.2
6.06
2694
24760
(3010813) Leukocytes [#/volume] in Blood
2751
25340
1.60
18.80
30.8
25.9
e9/l
7.1
6.9
0.99
2635
24369
(3001604) Monocytes [#/volume] in Blood
1444
11841
1.40
18.69
7.0
5.4
e9/l
0.6
0.6
2.17
1245
9977
(3021589) Normoblasts [#/volume] in Blood
1279
10283
1.41
18.53
13.1
10.2
e9/l
0.0
0.0
0.91
1081
8245
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2671
24457
1.55
18.52
12.6
11.0
u/l
23.5
24.0
0.59
2554
23253
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1522
12649
1.39
17.90
7.4
5.7
mmol/l
1.2
1.2
1.76
1365
11268
(3013115) Eosinophils [#/volume] in Blood
1484
12283
1.39
17.88
7.1
5.6
e9/l
0.2
0.2
1.50
1293
10523
(3031040) Bacteria [#/volume] in Urine by Automated count
2003
17423
1.40
17.87
6.0
5.5
e6/l
136.7
3448.0
6.33
29
313
(40761511) CBC panel - Blood by Automated count
2606
23783
1.51
17.87
20.2
17.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2407
21652
1.45
17.54
20.1
16.8
ml/min/173m2
70.5
71.7
1.64
1982
17899
(3030467) Casts [#/volume] in Urine by Automated count
986
7638
1.42
17.41
3.9
3.4
e6/l
0.4
0.5
1.97
767
5867
(3026782) Osmolality of Urine
765
5669
1.46
17.15
3.2
2.9
mosm/kgh2o
510.9
539.9
3.69
661
4809
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1657
14025
1.38
17.11
8.2
6.5
mmol/l
1.2
1.2
0.10
1366
11731
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1293
10522
1.38
16.98
2.5
2.2
nmol/l
78.3
80.1
1.39
1119
9085
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
966
7496
1.41
16.76
2.4
2.3
mg/l
3.1
3.2
0.15
815
6307
(3014148) Varicella zoster virus Ab [Titer] in Serum
51
137
3.77
16.72
1.1
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
947
7329
1.41
16.66
4.0
3.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
54
152
3.60
16.54
1.2
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1179
9519
1.38
15.97
4.9
3.9
e6/l
133.6
141.5
0.09
871
6916
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1225
9993
1.37
15.40
3.3
2.9
ug/l
147.5
146.0
0.07
1084
8969
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
426
2857
1.57
15.26
3.8
3.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1050
8373
1.38
15.16
4.1
3.5
e6/l
157.8
76.2
0.65
823
6505
(3023368) Bacteria identified in Blood by Culture
1047
8346
1.38
15.15
4.9
4.2
—
—
—
0
0
(3044889) 12 lead EKG panel
1929
16894
1.36
15.13
4.6
4.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1441
12089
1.35
14.96
4.6
4.3
estimate
0.0
0.0
0.00
331
2186
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2390
21706
1.40
14.60
7.6
6.5
mmol/mol
42.7
41.0
11.78
2126
19546
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2360
21398
1.39
14.49
5.1
5.0
mu/l
2.1
2.1
0.22
2090
19029
(3009542) Hematocrit [Volume Fraction] of Blood
2243
20188
1.37
14.28
23.7
19.3
%
37.1
38.0
2.82
1380
12327
(3032080) INR in Blood by Coagulation assay
1391
11673
1.34
14.14
11.8
11.1
inr
1.3
1.4
0.09
415
3053
(3013707) Erythrocyte sedimentation rate by Westergren method
2027
17987
1.34
13.99
4.6
4.2
mm/h
15.9
15.0
1.36
1846
16317
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
53
166
3.23
13.81
1.1
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
332
2172
1.59
13.16
1.7
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1415
11994
1.32
13.05
5.2
4.5
g/l
34.0
34.5
2.57
1298
10969
(3003458) Phosphate [Moles/volume] in Serum or Plasma
506
3630
1.47
13.05
8.6
5.0
mmol/l
1.1
1.0
2.51
465
3287
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
35
86
4.10
13.01
1.1
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1167
9634
1.33
12.92
4.0
3.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1442
12277
1.32
12.80
4.8
4.4
estimate
0.0
0.0
0.44
313
2151
(3013650) Neutrophils [#/volume] in Blood by Automated count
1615
13994
1.31
12.50
9.2
8.4
e9/l
4.4
4.3
0.55
1403
12044
(3012516) Albumin [Mass/volume] in Urine
967
7798
1.34
12.45
3.8
3.1
mg/l
366.9
323.8
0.11
632
4910
(3021960) Folate [Moles/volume] in Serum or Plasma
888
7070
1.35
12.44
1.6
1.6
nmol/l
20.6
20.4
0.12
758
5910
(3021601) Nitrite [Presence] in Urine by Test strip
1421
12110
1.31
12.38
6.3
5.8
estimate
0.0
0.0
0.50
327
2163
(3020682) Albumin/Creatinine [Ratio] in Urine
1016
8265
1.34
12.30
4.8
3.9
mg/mmol
17.8
9.0
2.84
665
5161
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
595
4447
1.41
12.23
3.4
3.1
e6/l
1.9
2.7
2.70
342
2487
(40768446) Kidney Pathology biopsy report
28
61
4.62
12.11
1.9
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
344
2322
1.54
11.86
4.9
3.4
ng/l
107.4
94.9
1.30
291
1921
(3013826) Glucose [Moles/volume] in Serum or Plasma
1754
15443
1.30
11.73
6.3
4.6
mmol/l
7.1
6.9
4.02
1648
14519
(3009508) Creatinine [Moles/volume] in Urine
979
7968
1.33
11.68
3.7
3.1
mmol/l
6.5
6.8
1.84
797
6520
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
81
349
2.36
11.56
1.7
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2462
22742
1.35
11.51
5.5
5.2
mmol/l
2.5
2.6
5.47
2178
20299
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
81
350
2.35
11.49
1.7
1.2
—
18.4
—
0
7
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
1176
9847
1.31
11.37
4.2
3.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1557
13540
1.29
11.25
5.5
5.9
umol/l
11.9
12.2
0.26
1459
12762
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
116
594
1.99
10.74
3.8
2.6
mg/l
1.8
1.7
0.34
106
521
(3022948) Iron [Moles/volume] in Serum or Plasma
591
4506
1.38
10.67
3.4
2.5
umol/l
11.2
11.9
1.63
540
4102
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
526
3935
1.40
10.63
3.6
2.5
%
20.8
21.2
0.35
438
3304
(3025159) Blasts/100 leukocytes in Blood
272
1788
1.57
10.54
3.9
4.1
%
0.1
0.3
0.51
75
478
(3024471) HLA-A [Type]
20
37
5.43
10.39
1.0
1.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
551
4181
1.38
10.21
3.5
2.5
g/l
2.2
2.3
4.05
500
3817
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
84
389
2.19
10.16
8.5
4.6
iu/ml
467.3
831.3
0.41
12
51
(3015736) pH of Urine
1136
9586
1.29
10.02
4.2
4.0
—
6.0
—
0
7
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
613
4745
1.36
10.01
3.3
2.9
e6/l
1.2
1.3
0.55
356
2766
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
877
7154
1.31
10.00
3.1
3.0
u/l
29.2
36.0
4.07
826
6727
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
70
303
2.34
9.94
1.9
1.3
u/ml
113.1
116.6
0.15
16
57
(3024932) HLA-DR beta [Type]
19
35
5.45
9.92
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2435
22608
1.32
9.92
5.2
5.0
mmol/l
6.3
6.1
8.62
2117
19930
(3000850) Epithelial cells [#/volume] in Urine
744
5946
1.33
9.79
3.2
2.7
e6/l
5.6
5.4
0.23
657
5219
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1958
17703
1.27
9.64
4.1
4.0
pmol/l
15.1
15.1
0.07
1718
15649
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
154
902
1.74
9.38
1.7
1.7
u/l
39.0
38.7
0.06
137
767
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1271
10939
1.27
9.38
4.6
4.3
ng/l
45.1
117.8
1.10
980
8442
(3012095) Magnesium [Moles/volume] in Serum or Plasma
559
4307
1.36
9.35
3.0
2.8
mmol/l
0.8
0.8
0.64
505
3923
(40767503) Oxygen content in Capillary blood by calculation
112
598
1.90
9.23
2.5
2.5
%
15.9
15.6
0.23
58
312
(40761536) Microorganisms panel - Urine sediment
294
2028
1.50
9.12
5.3
4.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
796
6477
1.30
9.11
1.9
1.8
nmol/l
1141.9
1161.9
0.24
586
4744
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2370
22033
1.29
8.85
4.9
4.6
mmol/l
4.4
4.5
4.08
2104
19732
(3042936) Bacteria identified in Isolate by Culture
490
3744
1.36
8.60
2.6
2.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2344
21793
1.28
8.55
4.8
4.6
mmol/l
1.4
1.5
1.18
2062
19383
(3041096) Erythrocytes [Presence] in Urine by Automated
761
6203
1.30
8.51
4.3
4.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
720
5827
1.30
8.50
1.8
1.6
mmol/l
1.3
1.3
0.03
587
4829
(3021440) Promyelocytes/100 leukocytes in Blood
279
1935
1.48
8.43
3.9
4.0
%
0.1
0.1
0.31
77
579
(3010421) pH of Blood
127
730
1.77
8.30
5.6
4.4
ph
7.4
7.4
2.82
107
605
(3002179) Metamyelocytes/100 leukocytes in Blood
266
1834
1.49
8.28
3.8
3.8
%
0.5
0.6
0.15
65
432
(3036481) Cortisol [Moles/volume] in Serum or Plasma
299
2110
1.46
8.27
2.0
2.0
nmol/l
382.8
378.6
0.14
266
1886
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
40
145
2.78
8.22
1.2
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
38
4.76
8.11
1.1
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
41
152
2.72
8.08
2.3
2.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
290
2044
1.46
8.08
3.9
4.0
%
0.8
0.9
0.56
80
627
(3033658) Prothrombin time (PT) actual/Normal
783
6461
1.28
7.88
4.6
3.8
%
85.5
84.3
0.63
764
6292
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1107
9526
1.25
7.78
3.2
3.2
ng/l
2124.4
1970.2
0.42
948
8262
(3027945) Reticulocytes/100 erythrocytes in Blood
472
3642
1.35
7.73
2.4
2.3
%
1.8
1.8
0.09
404
3153
(3012501) Base excess in Blood by calculation
110
620
1.80
7.70
5.4
4.7
mmol/l
2.6
2.8
0.49
76
437
(3000494) Fungus identified in Specimen by Culture
362
2682
1.39
7.65
1.5
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
796
6605
1.27
7.62
5.2
4.7
estimate
0.0
0.0
1.08
305
2075
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
322
2347
1.41
7.48
3.3
2.3
u/l
36.8
56.3
0.45
271
1975
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
318
2313
1.42
7.47
5.8
3.6
mmol/l
1.2
1.2
0.52
278
1974
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
87
460
1.92
7.45
5.5
2.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
88
472
1.89
7.23
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
745
6173
1.27
7.16
7.0
6.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
107
616
1.76
7.01
3.9
3.9
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
35
4.59
6.93
1.1
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
623
5079
1.28
6.79
1.9
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1090
9474
1.23
6.75
3.4
3.3
mmol/l
2.3
2.4
0.97
914
7989
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
83
451
1.86
6.58
4.3
3.4
%
56.8
59.3
0.72
83
451
(3037522) Nuclear Ab [Titer] in Serum
351
2651
1.36
6.58
1.3
1.3
titre
492.6
550.0
0.29
86
607
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
12
21
5.73
6.58
1.7
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1060
9207
1.23
6.57
5.1
4.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
173
1150
1.53
6.45
1.5
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1268
11244
1.21
6.32
2.5
2.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
633
5218
1.27
6.26
1.6
1.7
mg/l
1.6
1.5
0.22
494
4057
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
739
6204
1.25
6.24
1.8
1.7
pmol/l
27226482.2
14040841.1
0.29
584
4950
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2248
21069
1.22
6.23
4.3
4.1
mmol/l
1.3
1.3
0.12
1956
18538
(40768804) Tissue Pathology biopsy report
1085
9487
1.22
6.22
2.2
2.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
449
3556
1.31
6.08
1.9
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
932
8040
1.22
6.08
3.5
2.5
u/l
63.2
58.1
0.47
844
7316
(3018677) aPTT in Platelet poor plasma by Coagulation assay
529
4295
1.28
5.91
2.0
2.0
s
30.4
30.1
0.45
508
4137
(3020779) Urea [Moles/volume] in Serum or Plasma
331
2522
1.35
5.87
11.8
6.2
mmol/l
12.7
11.4
2.02
313
2355
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
211
1491
1.44
5.84
7.8
8.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
22
70
3.16
5.74
1.1
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
119
749
1.61
5.66
1.4
1.4
ug/g
264.5
276.6
0.30
76
444
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
443
3543
1.29
5.56
1.9
1.8
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
13
29
4.50
5.51
10.8
15.9
mmol/l
4.2
5.4
1.19
13
29
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
57
291
1.98
5.50
1.5
1.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
193
1360
1.45
5.44
7.9
3.3
mmol/l
23.6
24.2
1.64
174
1210
(3020630) Protein [Mass/volume] in Serum or Plasma
329
2545
1.33
5.27
2.4
2.5
g/l
66.5
66.0
0.65
281
2233
(3017143) Hepatitis C virus Ab [Presence] in Serum
246
1824
1.38
5.20
2.2
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
96
586
1.66
5.18
1.5
1.6
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
20
65
3.09
5.06
23.6
26.0
ug/l
102.5
114.4
0.43
15
53
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
665
5650
1.22
4.90
4.4
4.3
ng/l
459.5
485.0
0.04
583
4898
(3011397) Hemoglobin [Presence] in Urine by Test strip
702
6005
1.22
4.83
4.7
4.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
26
101
2.59
4.80
1.1
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
955
8415
1.19
4.78
2.1
2.1
u/l
160.8
218.3
2.70
879
7807
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
60
328
1.85
4.77
1.4
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
23
84
2.75
4.77
2.7
2.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
267
2037
1.34
4.72
2.2
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
416
3369
1.27
4.71
6.1
5.9
mmol/l
0.8
1.3
1.34
308
2593
(3006184) Hemoglobin [Mass/volume] in Capillary blood
106
680
1.58
4.71
2.0
2.2
g/l
123.8
125.6
0.28
81
490
(3027801) Oxygen [Partial pressure] in Arterial blood
416
3375
1.27
4.65
6.1
5.9
kpa
11.9
11.8
0.07
389
3184
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
416
3376
1.27
4.63
6.1
5.9
kpa
5.0
5.1
0.32
388
3185
(3052851) Hemolysis interference index of Serum or Plasma
133
901
1.50
4.63
4.1
3.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
162
1142
1.44
4.61
2.2
2.4
g/l
11.2
10.4
1.26
124
938
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
205
1508
1.38
4.58
7.3
7.3
mmol/l
23.8
24.5
1.62
189
1378
(3016502) Oxygen saturation in Arterial blood
373
2992
1.28
4.57
6.3
6.1
%
95.4
95.2
0.20
353
2866
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
56
305
1.85
4.52
1.4
1.1
u/ml
338.8
289.0
0.60
41
171
(3025941) Bacteria identified in Stool by Culture
171
1222
1.42
4.52
1.4
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
549
4614
1.23
4.47
5.2
4.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
69
402
1.73
4.47
1.3
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
44
224
1.98
4.35
1.4
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
130
889
1.48
4.34
2.4
2.5
g/l
0.1
0.0
0.11
109
794
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
137
951
1.46
4.25
2.3
2.4
g/l
36.1
37.0
1.02
108
781
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
523
4396
1.23
4.25
3.5
3.3
ug/l
0.8
0.8
0.81
384
3116
(3023520) Reticulocytes [#/volume] in Blood
341
2731
1.28
4.24
2.6
2.4
e9/l
70.9
68.6
0.59
253
2076
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77
474
1.64
4.10
1.7
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
141
992
1.44
4.09
3.0
3.1
ratio
2.0
1.6
—
7
78
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
156
1122
1.41
4.01
2.2
2.5
g/l
3.1
3.2
0.28
116
860
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
57
325
1.77
4.01
1.3
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
750
6558
1.19
4.00
2.8
2.8
umol/l
9426.1
7531.2
0.37
608
5473
(46235355) HIV 1 and 2 tests - Meaningful Use set
293
2320
1.29
3.99
2.1
1.6
—
—
—
0
0
(3013512) EKG study
907
8061
1.17
3.98
4.6
4.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1476
13627
1.15
3.90
3.1
3.1
u/l
49.2
54.4
1.57
1336
12282
(3002173) Hemoglobin [Mass/volume] in Arterial blood
336
2715
1.27
3.89
6.9
6.5
g/l
118.2
118.9
0.26
320
2613
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
879
7805
1.17
3.89
5.6
5.4
ug/l
4.0
4.6
0.25
765
6857
(3048929) Epstein Barr virus Ab [Presence] in Serum
71
435
1.65
3.87
1.4
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
52
292
1.79
3.86
1.2
1.2
miu/ml
244.1
238.8
—
10
106
(3036489) Thrombin time
117
804
1.47
3.85
1.8
1.9
s
21.7
21.6
0.02
104
736
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
165
1209
1.38
3.82
2.2
2.4
g/l
4.2
3.8
1.25
113
840
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
165
1211
1.38
3.79
2.2
2.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
142
1016
1.42
3.78
3.0
3.1
mg/l
32.9
68.9
1.86
115
842
(3009343) pH of Capillary blood
237
1839
1.31
3.77
3.6
3.6
ph
7.4
7.4
0.56
45
227
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
165
1213
1.38
3.75
2.2
2.4
g/l
7.8
7.5
0.97
115
873
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
349
2847
1.25
3.73
2.7
2.4
umol/l
10.8
9.6
0.25
290
2439
(3034860) Kappa light chains.free [Mass/volume] in Serum
142
1019
1.41
3.72
3.1
3.1
mg/l
51.0
117.4
0.64
115
842
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
230
1781
1.31
3.72
3.6
3.5
mmol/l
1.7
2.0
0.49
154
1307
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
143
1028
1.41
3.71
2.4
2.6
g/l
1.4
1.2
0.22
111
854
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
90
592
1.54
3.66
1.9
2.1
%
91.6
88.4
0.74
84
565
(3002032) Base excess in Venous blood by calculation
349
2856
1.25
3.64
6.0
3.3
mmol/l
1.3
2.1
3.17
275
2290
(3021447) Carbon dioxide [Partial pressure] in Venous blood
350
2869
1.25
3.59
5.7
3.3
kpa
5.9
5.8
0.20
332
2782
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
90
595
1.53
3.59
1.6
1.6
iu/ml
0.6
1.2
0.23
20
147
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
111
767
1.46
3.58
1.9
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
238
1862
1.30
3.58
3.7
3.6
kpa
5.2
5.2
0.16
214
1683
(3014111) Lactate [Moles/volume] in Serum or Plasma
312
2526
1.26
3.57
7.1
5.4
mmol/l
1.4
1.4
0.07
302
2421
(3028433) Virus identified in Specimen by Culture
20
80
2.51
3.54
1.1
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
30
144
2.09
3.53
1.3
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
30
145
2.08
3.47
1.3
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
511
4370
1.20
3.47
1.3
1.2
u/ml
1.2
1.6
0.44
130
1060
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
117
823
1.44
3.45
2.4
2.5
g/l
0.0
0.0
0.00
99
744
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
644
5629
1.18
3.41
3.1
3.0
mmol/l
2.5
2.5
0.00
537
4873
(3024980) IgG subclass 4 [Mass/volume] in Serum
49
282
1.75
3.39
1.4
1.5
g/l
0.5
0.9
2.46
36
212
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
228
1788
1.30
3.38
1.5
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
294
2381
1.26
3.37
10.1
6.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
118
836
1.43
3.35
2.4
2.5
g/l
0.0
0.0
0.00
99
745
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
52
306
1.71
3.34
1.3
1.4
u/l
783.1
292.3
0.49
46
291
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
169
1.96
3.28
1.3
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
109
765
1.44
3.27
2.5
3.1
mmol/l
24.7
25.2
0.46
102
663
(3045424) Erythrocytes [Presence] in Urine
63
393
1.62
3.25
1.4
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
268
2158
1.26
3.23
2.5
2.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
87
588
1.49
3.17
1.4
1.5
g/l
0.2
0.2
0.52
82
554
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
90
616
1.47
3.09
2.1
2.2
g/l
3.7
3.6
0.22
81
583
(3048689) Calprotectin [Mass/mass] in Stool
279
2272
1.25
3.06
2.0
1.9
ug/g
108.3
159.0
2.77
213
1731
(3003181) Sodium [Moles/volume] in Urine
85
577
1.49
3.04
1.3
1.3
mmol/l
59.6
61.2
0.16
69
454
(3027135) IgG subclass 1 [Mass/volume] in Serum
32
167
1.93
3.04
1.3
1.3
g/l
6.5
7.1
0.43
20
118
(3024139) IgG subclass 3 [Mass/volume] in Serum
32
167
1.93
3.04
1.4
1.3
g/l
0.3
0.4
1.28
20
118
(3028192) IgG subclass 2 [Mass/volume] in Serum
32
167
1.93
3.04
1.3
1.3
g/l
3.0
2.8
0.15
20
119
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
86
586
1.48
3.03
1.4
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
50
300
1.68
3.02
1.4
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
36
196
1.85
3.02
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
106
755
1.42
2.97
1.5
1.6
—
—
—
0
0
(3000492) Spirometry study
223
1779
1.27
2.93
1.7
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
42
243
1.74
2.90
1.2
1.2
u/ml
5.3
4.6
0.08
14
73
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
244
1971
1.26
2.89
1.8
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
148
1119
1.34
2.89
2.7
2.7
u/ml
0.3
0.4
1.06
76
671
(3036525) Urea [Moles/time] in 24 hour Urine
7
13
5.39
2.87
3.3
4.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
394
3351
1.20
2.85
3.3
3.8
u/l
243.0
248.7
0.41
360
3115
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
137
1028
1.35
2.82
1.4
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
87
604
1.45
2.81
1.4
1.5
g/l
1.2
1.2
0.53
82
569
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
46
276
1.68
2.80
1.4
1.3
pmol/l
270.6
260.4
0.07
35
201
(3052592) Norovirus Ag [Presence] in Stool
16
65
2.47
2.78
1.1
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
146
1109
1.33
2.77
2.0
2.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
21
97
2.17
2.76
1.5
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
29
152
1.92
2.75
1.7
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
88
616
1.44
2.73
1.5
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
68
452
1.52
2.73
1.5
1.6
—
—
—
0
0
(3025315) Body weight
7
14
5.01
2.72
5.7
4.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
57
365
1.57
2.70
1.5
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
289
2399
1.22
2.69
4.8
2.8
kpa
4.7
4.4
1.24
272
2317
(40760888) Immunoglobulin light chains.free panel - Serum
106
771
1.39
2.66
3.0
3.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
79
545
1.46
2.65
2.2
2.4
%
209.5
204.5
0.21
72
521
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
88
621
1.43
2.63
1.4
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
15
62
2.43
2.54
1.8
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
36
208
1.74
2.53
2.6
2.2
ml
588.7
635.1
0.35
22
122
(3019060) Gas panel - Arterial blood
243
1995
1.24
2.52
3.9
4.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
29
157
1.85
2.52
1.2
1.2
—
—
—
0
0
(4062490)
31
172
1.81
2.50
1.4
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
129
979
1.33
2.50
2.4
2.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
444
3862
1.17
2.49
1.7
1.5
g/l
2.4
2.7
1.48
250
2165
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
695
6252
1.14
2.47
4.6
4.7
%
22.9
22.1
0.67
344
3299
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
11
39
2.83
2.47
1.1
1.2
—
—
—
0
0
(3036603) Volume of Urine
27
144
1.88
2.46
2.0
1.5
ml
1701.8
1768.3
—
5
42
(3011985) Renin [Units/volume] in Plasma
47
295
1.60
2.45
1.5
1.3
mu/l
49.8
59.4
0.23
40
253
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
17
76
2.24
2.44
1.0
1.1
ratio
1.1
1.1
—
8
22
(3008295) Osmolality of Serum or Plasma
44
272
1.63
2.43
1.5
1.3
mosm/kgh2o
272.1
275.2
0.47
36
190
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
71
489
1.46
2.43
1.7
1.7
iu/l
2.8
4.5
2.31
20
155
(3017732) Neutrophils [#/volume] in Blood
193
1554
1.26
2.39
3.3
3.2
e9/l
4.5
4.1
1.08
139
1107
(3020876) Protein [Mass/time] in 24 hour Urine
36
212
1.71
2.39
1.9
1.9
—
1.0
—
0
7
(3003434) Protein [Mass/volume] in Pleural fluid
68
467
1.47
2.37
1.5
1.6
g/l
29.1
30.5
0.33
61
419
(40768797) Stomach Pathology biopsy report
377
3249
1.18
2.37
1.2
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
8
22
3.64
2.36
1.0
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
169
1343
1.27
2.34
2.5
2.5
au/ml
27.8
25.1
—
5
45
(3004451) EKG impression Narrative
27
147
1.84
2.32
1.4
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
43
268
1.61
2.32
1.3
1.3
nmol/l
—
—
—
0
0
(3022145) Colonoscopy Study observation
295
2494
1.20
2.31
1.3
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
94
689
1.38
2.30
1.6
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
26
141
1.85
2.27
2.6
2.2
ug/min
45.1
78.1
—
9
27
(3038177) Helicobacter pylori Ab [Presence] in Serum
42
262
1.61
2.26
1.2
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
26
142
1.84
2.23
2.6
2.0
min
487.5
497.7
0.20
18
96
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
9
5.56
2.21
5.8
5.3
—
—
—
0
0
(3002256) Pathology report gross observation
366
3167
1.18
2.20
1.4
1.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
87
635
1.38
2.20
5.5
6.2
mmol/l
105.0
104.9
0.06
76
569
(3039000) Anion gap in Blood
87
635
1.38
2.20
5.5
6.2
mmol/l
11.6
11.0
0.92
76
569
(3005322) IgE [Units/volume] in Serum or Plasma
135
1053
1.29
2.19
1.2
1.2
u/ml
237.4
200.1
0.13
122
954
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1241
11635
1.11
2.15
4.4
4.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
54
362
1.50
2.15
1.2
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
157
1252
1.27
2.14
4.5
4.6
%
0.9
0.9
1.03
143
1181
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
98
733
1.35
2.13
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
98
733
1.35
2.13
1.3
1.3
—
—
—
0
0
(4034850)
55
800
0.68
2.13
19.7
12.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1935
18562
1.11
2.12
28.5
23.5
g/l
329.8
330.6
3.74
1907
18316
(3019420) Tryptase [Mass/volume] in Serum or Plasma
18
88
2.05
2.11
2.2
1.3
ug/l
15.5
9.6
0.29
18
75
(3026480) Teichoate Ab [Titer] in Serum
8
25
3.21
2.09
1.1
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
34
206
1.66
2.07
1.7
2.0
u/l
399.1
2215.8
—
5
78
(3018851) Theophylline [Moles/volume] in Serum or Plasma
9
31
2.91
2.07
1.8
1.5
umol/l
55.9
43.4
—
9
31
(3051611) Lipemic interference index of Serum or Plasma
51
341
1.50
2.06
3.8
3.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
94
703
1.35
2.06
2.6
3.0
kpa
8.1
7.9
0.54
89
646
(21494815) CD4 cells/100 lymphocytes in Specimen
26
146
1.79
2.06
1.9
1.9
%
39.9
40.5
—
7
15
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
63
440
1.44
2.06
8.7
1.4
nmol/l
0.8
0.8
0.03
51
353
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
20
3.51
2.05
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
161
0.37
2.01
1.3
1.6
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
21
3.34
1.96
1.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
21
3.34
1.96
1.0
1.1
%
90.3
98.0
—
7
21
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
18
91
1.98
1.95
3.6
2.9
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
114
885
1.30
1.95
5.1
5.6
mmol/l
1.2
1.3
0.64
98
783
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
16
3.75
1.93
1.0
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
902
8357
1.11
1.93
2.6
2.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
21
113
1.86
1.91
1.1
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
48
323
1.49
1.91
1.3
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
35
219
1.60
1.90
2.6
3.1
mg/l
66.2
22.3
0.46
25
168
(3014576) Chloride [Moles/volume] in Serum or Plasma
410
3626
1.15
1.88
7.3
5.7
mmol/l
104.6
104.1
1.06
401
3525
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
15
72
2.09
1.86
1.1
1.5
%
13.2
22.8
—
10
61
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
106
821
1.30
1.85
1.1
1.1
—
1.7
—
0
9
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
17
86
1.98
1.84
1.1
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
13
59
2.21
1.84
2.7
2.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
12
4.17
1.82
3.0
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
34
214
1.60
1.82
1.1
1.1
%
107.0
114.0
0.68
29
192
(3021387) Prolactin [Units/volume] in Serum or Plasma
49
335
1.47
1.82
2.0
1.6
mu/l
375.7
284.5
0.74
44
304
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
129
1028
1.27
1.81
2.2
2.1
ug/l
660.9
594.6
0.07
120
964
(40768806) Pleura Pathology biopsy report
52
360
1.45
1.81
1.5
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
39
254
1.54
1.81
1.4
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
156
1272
1.24
1.80
1.7
1.8
ug/l
2.9
2.3
0.23
127
1081
(3051101) Glucose [Moles/volume] in Cord blood
13
60
2.17
1.77
6.3
5.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
77
574
1.35
1.77
2.5
2.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
42
281
1.50
1.74
1.3
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
155
1269
1.23
1.73
4.4
4.6
%
1.6
1.6
0.02
142
1198
(4306422)
34
217
1.57
1.73
1.3
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
37
241
1.54
1.73
1.3
1.2
u/ml
1.9
5.1
—
10
116
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
34
218
1.57
1.70
1.2
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
108
853
1.28
1.66
1.4
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
59
427
1.39
1.64
1.4
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
151
1242
1.23
1.63
3.2
3.1
pmol/l
4.4
4.4
0.04
130
1061
(3047189) Immunofixation for 24 hour Urine
22
128
1.72
1.60
1.7
1.6
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
52
370
1.41
1.60
6.5
6.2
mg/l
11.6
12.6
0.90
45
337
(3010503) CD19 cells [#/volume] in Blood
21
121
1.74
1.58
2.6
2.0
e9/l
0.1
0.1
0.91
21
114
(3016330) Potassium [Moles/time] in 24 hour Urine
6
20
3.00
1.58
1.2
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
85
656
1.30
1.57
2.9
2.3
ug/min
92.2
77.5
0.17
45
377
(3011412) CD3 cells [#/volume] in Blood
29
183
1.59
1.57
2.7
2.0
e9/l
0.8
1.0
0.60
14
108
(3011648) Oxygen content in Venous blood
29
183
1.59
1.57
3.2
1.5
%
10.6
10.6
0.01
29
183
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
22
129
1.71
1.56
2.6
1.9
e6/l
450.2
645.5
1.30
13
56
(3022493) Free Hemoglobin [Mass/volume] in Plasma
19
107
1.78
1.54
1.4
4.9
mg/l
45.2
65.4
1.45
12
72
(3024928) Oxygen saturation in Venous blood
75
571
1.32
1.53
5.2
2.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
157
1307
1.21
1.53
2.2
1.8
g/l
1.5
1.4
0.05
139
1157
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
48
340
1.42
1.52
1.1
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
192
1631
1.19
1.51
3.0
2.7
g/l
10.3
10.7
0.67
174
1466
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
279
2443
1.16
1.51
1.3
1.4
—
—
—
0
0
(4027681)
16
86
1.86
1.50
1.3
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
44
308
1.43
1.49
1.1
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
151
1256
1.21
1.49
2.2
2.1
nmol/l
10.3
11.6
1.11
134
1071
(1761868) Lipid panel - Serum or Plasma
658
6078
1.10
1.48
3.3
3.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
217
1867
1.17
1.47
4.9
3.0
g/l
122.4
126.7
2.03
206
1824
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
32
211
1.52
1.45
1.2
1.5
—
1466.7
—
0
6
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
181
1536
1.19
1.45
1.8
1.7
g/l
1.5
1.5
0.07
150
1303
(40768443) Skin Pathology biopsy report
134
1106
1.22
1.44
1.2
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
137
1134
1.22
1.43
4.5
3.9
mmol/l
24.3
24.9
1.00
114
1018
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
40
2.25
1.40
1.4
1.5
ng/l
120.9
109.5
—
9
40
(3051651) Icteric interference index of Serum or Plasma
28
181
1.55
1.40
4.7
3.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
687
6377
1.10
1.39
2.6
2.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
58
432
1.35
1.39
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
187
1598
1.18
1.39
2.7
2.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
53
2.08
1.38
1.2
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
28
182
1.54
1.37
2.4
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
57
755
0.75
1.36
1.3
1.4
—
—
—
0
0
(4281824)
16
273
0.58
1.35
1.4
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
12
61
1.97
1.32
1.0
1.0
miu/ml
2161.6
1688.9
0.65
12
61
(3012441) Differential panel - Pleural fluid
50
368
1.36
1.31
1.6
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
51
378
1.35
1.28
28.4
5.7
mmol/l
8.0
7.4
0.40
44
311
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
48
2.09
1.27
1.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
130
1.62
1.26
1.6
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
55
414
1.33
1.26
1.1
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
93
751
1.25
1.25
1.2
1.2
u/ml
0.3
0.6
0.54
14
64
(3016650) Hepatitis A virus Ab [Presence] in Serum
40
286
1.40
1.25
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
152
1779
0.85
1.22
1.3
1.7
%
1.7
1.5
0.98
115
1493
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
380
3453
1.11
1.19
1.3
1.3
iu/ml
48.7
39.8
0.34
122
1064
(3001893) Eosinophils/100 leukocytes in Pleural fluid
18
109
1.66
1.18
1.2
1.6
%
6.3
2.4
0.38
12
87
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
20
125
1.60
1.17
1.3
1.6
%
62.3
68.0
0.36
13
98
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
25
165
1.52
1.17
1.0
1.0
ng/l
37.1
44.2
0.45
17
102
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
25
165
1.52
1.17
1.0
1.0
ng/l
523.2
663.7
1.34
16
99
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
39
282
1.39
1.16
3.3
2.3
u/field
3.2
2.1
0.17
12
87
(3009214) Lutropin [Units/volume] in Serum or Plasma
42
308
1.37
1.15
2.0
1.4
u/l
15.9
11.1
0.64
29
245
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
20
2.50
1.15
1.4
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
46
609
0.75
1.13
1.5
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
77
617
1.25
1.13
1.2
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
40
292
1.37
1.13
1.4
1.5
%
54.8
62.6
0.51
20
195
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
36
258
1.40
1.13
1.1
1.2
u/l
63.8
54.1
0.28
24
174
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
112
0.45
1.12
1.2
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
21
2.38
1.09
1.2
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
24
160
1.50
1.09
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
67
531
1.27
1.09
1.8
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
11
194
0.57
1.09
1.1
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
32
2.19
1.08
1.9
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
43
321
1.34
1.07
1.4
1.3
iu/l
31.6
31.3
0.02
37
271
(36660697) Celiac disease serology panel - Serum
181
1582
1.15
1.07
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
112
941
1.20
1.07
1.0
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
324
2940
1.11
1.06
3.3
3.2
ng/l
302.8
252.1
0.97
291
2689
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
87
714
1.22
1.05
1.1
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
75
921
0.81
1.03
1.8
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
18
276
0.65
1.03
1.3
2.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
34
2.06
1.03
1.1
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
34
2.06
1.03
1.1
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
67
536
1.26
1.02
1.6
2.3
umol/l
32.3
31.9
0.03
49
434
(3023199) Leukocytes [#/volume] in Pleural fluid
54
421
1.29
1.01
1.6
1.5
e6/l
1480.4
2024.7
0.41
40
302
(3028308) Erythrocytes [#/volume] in Pleural fluid
50
386
1.30
1.01
1.6
1.5
e6/l
33412.6
46689.0
0.42
27
234
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
24
164
1.47
0.99
1.0
1.0
ng/l
295.5
315.6
0.19
17
103
(3027944) Amphetamines [Presence] in Urine
18
273
0.66
0.99
1.3
2.0
—
—
—
0
0
(3019977) pH of Arterial blood
26
181
1.44
0.98
2.7
2.5
ph
7.4
7.4
0.66
12
63
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
76
621
1.23
0.97
1.4
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
25
173
1.45
0.97
2.7
2.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
40
301
1.33
0.97
1.4
1.6
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
24
165
1.46
0.96
1.6
1.5
u/l
1.7
7.5
2.85
12
77
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
(4035726)
246
2215
1.12
0.95
1.3
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
14
85
1.65
0.94
1.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
62
1.78
0.94
1.2
1.3
—
—
—
0
0
(4133840)
7
37
1.89
0.94
1.6
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
44
338
1.31
0.93
1.4
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
93
780
1.20
0.93
1.6
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
309
2822
1.11
0.92
2.3
2.5
ug/l
7.6
6.6
0.22
246
2347
(3037692) Legionella sp identified in Specimen by Organism specific culture
13
78
1.67
0.91
1.6
1.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
18
118
1.53
0.90
1.8
1.6
nmol/l
13.6
16.8
1.21
18
104
(3004616) Nuclear Ab [Presence] in Serum
36
270
1.34
0.90
1.1
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
51
402
1.27
0.90
1.2
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
255
0.66
0.90
1.2
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
58
465
1.25
0.90
1.5
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
212
2360
0.89
0.89
5.0
3.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
11
182
0.60
0.89
1.5
3.0
—
—
—
0
0
(1002224) Polysomnography panel
62
502
1.24
0.88
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
19
277
0.68
0.88
1.4
2.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
211
1893
1.12
0.88
5.8
6.1
mmol/l
24.4
24.6
0.38
191
1766
(3002619) Bacteria identified in Specimen by Culture
10
56
1.79
0.87
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
39
298
1.31
0.87
1.4
1.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
86
722
1.20
0.87
1.1
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
25
178
1.41
0.86
1.6
1.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
8
44
1.82
0.85
1.3
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
19
275
0.69
0.85
1.3
2.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
12
72
1.67
0.85
1.2
1.6
ug/l
0.3
0.4
—
5
37
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
31
1.94
0.84
1.2
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
224
2024
1.11
0.83
1.4
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
10
57
1.76
0.83
1.3
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
10
57
1.76
0.83
1.2
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
107
920
1.17
0.83
4.4
4.9
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
22
308
0.71
0.83
3.0
2.0
u/ml
63.7
995.6
0.56
22
299
(42529406) Shigella sp [Presence] in Stool by Culture
86
726
1.19
0.83
1.1
1.2
—
—
—
0
0
(4094501)
45
567
0.79
0.82
1.0
1.1
—
—
—
0
0
(4212803)
6
32
1.88
0.81
1.0
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
13
81
1.61
0.81
11.3
6.2
mmol/l
25.1
24.8
0.12
13
71
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
35
454
0.77
0.81
1.4
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
27
198
1.37
0.80
1.3
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
107
924
1.16
0.80
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
259
0.69
0.79
1.3
2.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
70
583
1.21
0.79
1.3
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
24
173
1.39
0.78
18.3
16.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
49
394
1.25
0.77
2.8
2.2
mg/l
24.4
23.1
0.07
14
97
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
29
217
1.34
0.76
1.1
1.2
mmol/l
7.7
7.7
0.00
24
144
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
273
2507
1.10
0.76
1.9
2.0
g/l
0.2
0.2
0.13
253
2305
(3034891) Synovial lining cells/100 cells in Synovial fluid
16
107
1.50
0.76
1.1
1.4
%
4.4
2.4
—
5
21
(3014891) Appearance of Pleural fluid
9
53
1.70
0.75
1.6
1.5
—
—
—
0
0
(4015189)
12
75
1.60
0.74
2.6
1.9
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
55
450
1.23
0.74
1.2
1.3
e6/l
72.5
29.0
0.26
37
354
(3020491) Glucose [Moles/volume] in Blood
24
175
1.37
0.74
1.6
2.8
mmol/l
7.6
7.0
0.30
16
122
(3013637) Mi-2 Ab [Presence] in Serum
9
54
1.67
0.74
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
54
1.67
0.74
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
54
1.67
0.74
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
54
1.67
0.74
1.1
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
38
1.84
0.73
48.6
7.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
39
307
1.27
0.73
4.9
3.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
55
451
1.22
0.73
1.2
1.3
e6/l
62.0
616.6
1.55
40
370
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
9
55
1.64
0.73
1.0
1.0
%
100.9
96.4
—
9
41
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
108
1.48
0.73
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
108
1.48
0.73
1.1
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
135
0.59
0.73
1.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
135
0.59
0.73
1.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
135
0.59
0.73
1.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
135
0.59
0.73
1.0
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
60
498
1.21
0.71
1.4
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
145
1292
1.13
0.71
2.0
2.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
128
1133
1.14
0.70
3.0
2.7
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
57
472
1.21
0.70
1.3
1.2
u/l
35.6
45.4
0.33
44
405
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
41
1.71
0.70
1.4
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
142
0.63
0.69
1.1
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
42
1.67
0.68
1.3
1.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
34
266
1.28
0.68
1.3
1.2
nmol/l
414.8
322.0
1.88
27
209
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
31
240
1.29
0.67
1.3
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
134
1194
1.13
0.67
2.0
1.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
26
197
1.32
0.65
1.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
175
1588
1.11
0.64
3.8
4.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
95
1.48
0.64
1.3
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
8
50
1.60
0.61
1.0
1.8
ug/l
3.9
1.5
—
8
44
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
52
1.54
0.59
1.1
1.3
—
—
—
0
0
(4268621)
22
166
1.33
0.58
2.4
2.3
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
2.2
—
1.8
—
0
15
(3006922) Hepatitis E virus Ab [Presence] in Serum
16
115
1.39
0.56
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
87
0.57
0.56
3.0
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
10
65
1.54
0.55
1.6
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
10
148
0.67
0.55
1.0
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
23
177
1.30
0.54
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
126
0.63
0.54
1.0
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
47
395
1.19
0.53
2.6
2.8
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
61
525
1.17
0.53
1.1
1.2
u/ml
2.5
8.1
—
8
93
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
40
1.50
0.51
1.3
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
135
1.34
0.51
2.7
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
28
347
0.81
0.50
1.4
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
65
1.39
0.50
2.2
2.0
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
19
144
1.32
0.50
2.4
1.9
%
66.1
70.8
0.44
19
131
(3037121) Protein [Mass/volume] in Urine
110
991
1.11
0.50
3.3
2.8
g/l
0.3
0.3
0.16
44
364
(3005570) Glucose [Moles/volume] in Urine
36
297
1.21
0.50
2.0
2.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
118
1.36
0.50
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
17
127
1.34
0.49
1.2
1.2
u/ml
0.4
1.6
—
9
63
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
45
1.56
0.49
1.3
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
7
46
1.52
0.48
1.7
1.4
—
—
—
0
0
(44813793)
17
128
1.33
0.47
1.1
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
47
1.49
0.47
1.3
1.3
—
—
—
0
0
(4211845)
18
137
1.32
0.47
4.3
4.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
48
1.46
0.46
48.7
7.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
11
77
1.43
0.45
1.8
2.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
50
1.40
0.45
1.3
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
164
0.73
0.45
1.0
1.1
u/ml
0.3
2.4
—
6
64
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
21
165
1.27
0.45
1.8
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
21
165
1.27
0.45
1.8
1.3
—
—
—
0
0
(4146454)
38
320
1.19
0.44
2.8
2.7
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
37
311
1.19
0.44
2.9
4.0
umol/l
357.8
345.5
0.19
29
260
(3014051) Protein [Presence] in Urine by Test strip
70
620
1.13
0.44
2.3
2.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
39
330
1.18
0.44
1.7
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
17
130
1.31
0.44
4.4
4.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
28
229
1.22
0.43
1.4
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
571
5503
1.05
0.43
5.4
4.9
kg/l
1.0
1.0
0.64
108
890
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
18
139
1.30
0.43
2.3
2.0
%
9.0
16.3
—
7
55
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
14
104
1.35
0.43
1.4
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
14
104
1.35
0.43
1.4
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
34
285
1.20
0.42
1.9
1.9
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
27
221
1.22
0.42
1.4
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
37
313
1.18
0.42
3.7
4.4
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
17
131
1.30
0.42
1.0
1.1
u/l
87.2
79.5
0.24
12
94
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
17
131
1.30
0.42
1.0
1.1
u/l
16.5
26.1
—
10
92
(3022313) Gas panel - Capillary blood
144
1331
1.09
0.42
4.4
3.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
19
149
1.28
0.41
1.9
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
25
305
0.82
0.41
1.4
1.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
5
33
1.52
0.41
1.2
1.2
g/l
8.2
16.1
—
5
28
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
29.8
—
0
16
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
114
1.32
0.40
1.2
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
39
333
1.17
0.40
3.4
3.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
31
259
1.20
0.40
1.2
1.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
60
1.33
0.40
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
60
1.33
0.40
1.0
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
22
177
1.24
0.40
2.0
1.9
ug/l
2.2
1.9
0.47
16
149
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
44
380
1.16
0.40
1.5
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
20
159
1.26
0.40
1.8
2.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
102
0.69
0.39
1.9
1.7
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
1.0
1.3
nmol/l
3.7
5.7
—
5
26
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
148
0.74
0.38
4.6
3.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
19
151
1.26
0.38
1.9
2.0
u/field
3.0
2.7
0.06
13
101
(3044242) Glucose [Moles/volume] in Arterial blood
14
181
0.77
0.38
1.9
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
592
5731
1.04
0.38
1.4
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
89
1.35
0.38
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
197
1853
1.07
0.37
4.1
3.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
124
1146
1.09
0.37
1.2
1.2
iu/ml
88.5
126.8
0.95
36
400
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
112
0.71
0.37
1.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
112
0.71
0.37
1.0
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
14
107
1.31
0.37
1.4
1.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
69
1.31
0.37
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
114
0.70
0.37
1.0
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
125
1.28
0.37
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
17
134
1.27
0.36
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
17
134
1.27
0.36
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
17
134
1.27
0.36
1.4
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
58
516
1.13
0.36
1.1
1.2
u/ml
7.9
4.4
—
7
51
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
153
1429
1.07
0.36
4.5
2.3
%
0.7
0.7
0.21
147
1374
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
44
384
1.15
0.36
1.1
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
135
0.74
0.36
1.0
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
71
1.27
0.36
2.0
2.7
%
176.7
185.4
—
9
65
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
19
153
1.24
0.35
1.7
2.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
17
135
1.26
0.35
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
17
135
1.26
0.35
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
17
135
1.26
0.35
1.4
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
156
0.77
0.34
1.3
1.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
22
181
1.22
0.34
1.7
1.9
ug/l
3.8
3.1
0.28
17
162
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
44
1.36
0.34
1.8
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
26
218
1.19
0.34
1.4
1.3
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
11
82
1.34
0.34
2.0
2.0
%
7.0
7.7
0.10
11
77
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
46
1.30
0.33
1.2
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
86
0.70
0.33
5.2
2.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
169
1593
1.06
0.32
4.8
3.2
mmol/l
24.6
25.2
1.10
160
1553
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
26
220
1.18
0.31
1.0
1.0
u/ml
0.8
2.4
—
7
66
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
19
230
0.83
0.31
1.4
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
19
230
0.83
0.31
1.4
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
19
230
0.83
0.31
1.4
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
18
219
0.82
0.31
1.2
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
25
294
0.85
0.31
3.2
3.7
%
61.9
57.1
0.67
19
179
(3048879) Bone marrow aspiration report
7
99
0.71
0.30
1.3
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
218
0.82
0.30
1.3
2.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
13
102
1.28
0.30
1.0
1.0
u/ml
2.8
2.7
—
8
39
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
16
196
0.82
0.30
2.9
2.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
56
1.25
0.29
1.3
1.1
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
7
57
1.23
0.29
2.0
1.3
umol/l
2.3
2.0
—
7
52
(3006442) Creatine [Moles/volume] in Serum or Plasma
12
151
0.79
0.28
1.5
1.6
—
72.9
—
0
7
(3000093) Morphology [Interpretation] in Blood Narrative
32
280
1.14
0.27
1.1
1.2
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
8
64
1.25
0.27
3.0
1.9
%
9.4
8.8
—
8
54
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
64
1.25
0.27
1.3
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
79
854
0.92
0.27
1.5
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
76
701
1.09
0.27
1.3
1.3
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
8
65
1.23
0.27
3.0
1.9
%
28.0
28.1
—
8
57
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
35
309
1.13
0.27
1.1
1.1
iu/ml
11.5
77.7
—
6
58
(3043410) Blood group antigens tested for on Red Blood Cells
5
75
0.67
0.25
5.8
2.0
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
23
197
1.17
0.25
1.1
1.1
—
41.8
—
0
6
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
186
1945
0.95
0.24
2.5
2.9
ml/min/173m2
56.6
59.1
0.35
85
900
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
337
3264
1.04
0.24
4.9
4.7
%
33.5
33.7
0.12
211
2075
(3044941) Cell count panel - Synovial fluid
48
436
1.10
0.24
1.4
1.4
—
—
—
0
0
(3019225) pH of Specimen
306
2962
1.04
0.23
5.6
4.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
136
0.81
0.23
1.5
2.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
26
228
1.14
0.22
4.8
3.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
79
1.27
0.22
1.1
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
70
652
1.08
0.21
1.5
1.6
e6/l
9170.2
17411.3
2.20
51
470
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
1.5
—
0
10
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
2.3
—
0
10
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
339
3294
1.03
0.21
1.2
1.2
u/ml
26.8
14.9
1.12
103
1135
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(44806071)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
14
0.00
0.20
0.0
2.5
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
9.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
5.6
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
48
1.25
0.20
1.3
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
187
0.85
0.20
1.1
1.1
u/ml
0.4
1.0
—
7
67
(3014133) Dog dander IgE Ab [Units/volume] in Serum
13
108
1.20
0.20
1.0
1.0
u/ml
2.0
1.9
—
8
43
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
49
1.22
0.20
1.0
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
51
471
1.08
0.19
3.9
3.9
%
1.9
1.5
0.17
44
353
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
17
197
0.86
0.19
1.2
1.4
—
63.2
—
0
19
(44806420)
14
118
1.19
0.19
2.1
2.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
101
1.19
0.16
1.1
1.1
—
—
—
0
0
(44806118)
29
263
1.10
0.16
1.5
1.4
—
—
—
0
0
(44790049)
29
263
1.10
0.16
1.5
1.4
—
—
—
0
0
(44790047)
29
263
1.10
0.16
1.5
1.4
—
—
—
0
0
(44790048)
29
263
1.10
0.16
1.5
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
152
1465
1.04
0.16
1.2
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
120
1.17
0.16
1.4
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
16
139
1.15
0.16
1.4
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
16
139
1.15
0.16
1.4
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
16
139
1.15
0.16
1.4
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
16
139
1.15
0.16
1.4
1.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
28
254
1.10
0.16
1.2
1.2
e6/l
9351.7
149051.3
2.16
15
169
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
79
0.76
0.15
1.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
79
0.76
0.15
1.2
2.0
ug/l
19.8
117.0
—
6
71
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
27
245
1.10
0.15
1.2
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
121
1.16
0.15
1.4
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
83
1.08
0.14
1.2
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
49
522
0.94
0.14
1.5
1.7
mg/l
5.7
3.8
0.38
41
411
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
16
141
1.14
0.14
1.1
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
28
257
1.09
0.13
1.1
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
307
3133
0.98
0.13
3.5
3.7
ug/l
22.5
23.9
0.04
251
2592
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
63
599
1.05
0.12
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
54
570
0.95
0.12
1.1
1.4
—
—
—
0
0
(4010399)
167
1716
0.97
0.12
1.4
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
74
772
0.96
0.11
1.5
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
32
298
1.07
0.11
1.3
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
16
178
0.90
0.11
1.0
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
11
126
0.87
0.11
2.6
2.5
%
46.2
39.1
—
5
47
(3033705) Calcium.ionized [Moles/volume] in Venous blood
51
484
1.05
0.11
2.9
2.5
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
10
86
1.16
0.11
1.3
1.2
g/l
—
0.1
—
0
8
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
25
231
1.08
0.10
1.1
1.4
%
36.6
28.5
0.35
11
150
(3003740) Influenza virus B Ag [Presence] in Specimen
16
177
0.90
0.10
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
23
212
1.09
0.10
1.3
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
47
1.06
0.09
2.6
2.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
87
1.15
0.09
1.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
116
1.12
0.09
1.6
1.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
97
1.13
0.09
3.8
2.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
97
1.13
0.09
3.8
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
52
498
1.04
0.08
1.8
1.7
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
23
247
0.93
0.08
2.3
1.6
u/ml
17.6
23.5
—
7
55
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
56
1.07
0.08
1.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
56
1.07
0.08
1.0
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
57
1.05
0.08
1.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
60
0.83
0.08
1.2
1.5
ug/l
9.5
9.2
—
5
60
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
62
0.81
0.08
1.8
1.6
iu/ml
—
2024630.0
—
0
5
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
64
1.09
0.08
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
12
133
0.90
0.07
1.4
1.2
mmol/l
9.6
11.6
—
7
38
(3044007) Cell count panel - Peritoneal fluid
6
75
0.80
0.07
3.8
1.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
78
1.03
0.07
1.5
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
84
1.07
0.07
1.0
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
17
157
1.08
0.07
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
118
1205
0.98
0.06
5.9
4.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
37
354
1.05
0.06
1.8
2.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
25
264
0.95
0.06
1.7
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
109
1.10
0.06
1.2
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
23
217
1.06
0.06
1.2
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
343
3456
0.99
0.04
9.8
8.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
160
1.06
0.04
1.5
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
160
1.06
0.04
1.5
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
101
1.09
0.04
1.0
1.2
nmol/l
132.2
138.6
0.24
11
101
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
114
1157
0.98
0.04
2.9
3.8
u/ml
241.2
74.1
0.68
108
1114
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
129
0.93
0.03
5.4
6.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
12
112
1.07
0.03
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
66
649
1.02
0.02
3.8
3.8
mg/l
31.8
28.2
0.41
50
433
(4024509)
30
309
0.97
0.02
1.7
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
103
1041
0.99
0.02
2.7
3.0
u/ml
1866.7
2541.6
0.17
90
873
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
24
248
0.97
0.02
1.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
10
93
1.08
0.02
1.1
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
52
529
0.98
0.02
1.3
1.2
titre
73.3
90.8
—
6
37
(3013727) Leukocytes other/100 leukocytes in Blood
11
103
1.07
0.02
5.5
4.2
%
59.0
55.0
0.18
11
97
(44816559) Phosphatidylethanol [Mass/volume] in Blood
30
308
0.97
0.02
1.0
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
451
4497
1.00
0.01
31.5
30.6
inr
1.5
1.5
0.07
47
602
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
93
939
0.99
0.01
1.3
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
50
508
0.98
0.01
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
237
0.97
0.01
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
20
194
1.03
0.00
1.4
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
35
356
0.98
0.00
1.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
35
356
0.98
0.00
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
252
2514
1.00
0.00
1.3
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
13
131
0.99
0.00
1.0
1.0
u/ml
0.5
2.0
—
6
32
(3025468) Yersinia sp identified in Specimen by Organism specific culture
35
355
0.99
0.00
1.4
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
22
219
1.00
0.00
1.2
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
23
229
1.00
0.00
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
35
351
1.00
0.00
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
48
479
1.00
0.00
1.6
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
17
166
1.02
0.00
1.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
35
354
0.99
0.00
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
35
354
0.99
0.00
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
35
353
0.99
0.00
1.4
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
103
0.97
0.00
1.3
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
18
177
1.02
0.00
1.1
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
16
157
1.02
0.00
3.4
3.7
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
54
0.93
0.00
1.4
1.1
%
140.2
104.4
—
5
47
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
2.2
—
0
6
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
294.8
—
0
6
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
150
1.00
0.00
1.3
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
92
920
1.00
0.00
3.3
3.3
nmol/l
0.8
0.8
1.41
76
686
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
60
1.00
0.00
2.7
2.5
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
90
1.00
0.00
1.4
1.2
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
2.1
—
19.8
—
0
9
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
12.6
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
60
1.00
0.00
1.2
1.1
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
6
59
1.02
0.00
1.0
1.5
g/l
39.1
27.3
—
6
49
(3017509) Phencyclidine [Presence] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
64
0.94
0.00
1.2
1.1
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
1.9
—
4.4
—
0
8
(3036071) Salmonella sp Ab [Titer] in Serum
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
84
0.95
0.00
1.4
1.9
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
7.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
58
0.86
0.00
1.2
1.1
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint H7_GLAUCOMAMEDICATION and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_GLAUCOMAMEDICATION | 0.897 [0.84, 0.96] | 0.002 |
| Birth year | 0.99 [0.98, 1.0] | 0.019 |
During the follow-up period (1.1.1998 — 31.12.2019), 5847 out of 15112 females with H7_GLAUCOMAMEDICATION died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_GLAUCOMAMEDICATION | 0.969 [0.89, 1.06] | 0.483 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 3519 out of 9395 males with H7_GLAUCOMAMEDICATION died.
Mortality risk
Mortality risk for people of age
years, who have H7_GLAUCOMAMEDICATION.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.089% | 0.153% |
| 5 | 0.487% | 1.08% |
| 10 | 1.161% | 2.555% |
| 15 | 2.208% | 5.031% |
| 20 | 3.784% | 8.639% |
Relationships between endpoints
↥Index endpoint: H7_GLAUCOMAMEDICATION – Use of antiglaucoma preparations and miotics
GWS hits: 11
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data